v3.26.1
CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES
6 Months Ended
Jun. 30, 2026
CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES  
CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES

3.            CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES

The following table summarizes the Company’s cash, cash equivalents and marketable securities as of June 30, 2026 and December 31, 2025, respectively:

June 30, 2026

  ​ ​ ​

Amortized Cost

  ​ ​ ​

Unrealized Gains

  ​ ​ ​

Unrealized Losses

  ​ ​ ​

Fair Value

Cash and money market funds

$

20,935,187

$

$

$

20,935,187

U.S. treasuries

84,610,409

(55,704)

84,554,705

U.S. government agencies

43,365,916

(52,753)

43,313,163

Corporate bonds

39,896,893

(79,551)

39,817,342

Commercial papers

49,397,303

(82,918)

49,314,385

Total cash, cash equivalents and marketable securities

$

238,205,708

$

$

(270,926)

$

237,934,782

Classified as:

Cash and cash equivalents

$

20,935,187

Short-term marketable securities

216,999,595

Long-term marketable securities

Total cash, cash equivalents and marketable securities

$

237,934,782

December 31, 2025

  ​ ​ ​

Amortized Cost

  ​ ​ ​

Unrealized Gains

  ​ ​ ​

Unrealized Losses

  ​ ​ ​

Fair Value

Cash and money market funds

$

287,847,312

$

$

$

287,847,312

U.S. treasuries

29,998,449

283,154

30,281,603

Total cash, cash equivalents and marketable securities

$

317,845,761

$

283,154

$

$

318,128,915

Classified as:

Cash and cash equivalents

$

287,847,312

Short-term investments

30,281,603

Long-term investments

Total cash, cash equivalents and marketable securities

$

318,128,915

The contractual maturities of the Company's available-for-sale securities at June 30, 2026 did not exceed two years.

The Company does not intend to sell these investments for the purpose of realizing losses; however, the securities are classified as available-for-sale and may be sold in response to changes in market interest rates, liquidity needs, or other factors. The Company believes it is more likely than not that it will not be required to sell the investments before recovery of their amortized cost basis. Accordingly, the Company has determined that the available-for-sale securities that were in an unrealized loss position did not have any credit loss impairment as of June 30, 2026.